Paraskevi Giannakakou   Professor of Pharmacology in Medicine

Phone
  • +1 212 746 3783

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

  • First-in-Class Dual AR-V7/AR-fl Molecular Glue Degrader for Prostate Cancer Treatment  awarded by Daedalus Fund for Innovation (Weill Cornell) Principal Investigator 2024 - 2025
  • missing activity Principal Investigator 2018 - 2024
  • missing activity Principal Investigator 2023 - 2023
  • missing activity Principal Investigator 2019 - 2023
  • Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab  awarded by United States Department of Defense Co-Investigator 2020 - 2024
  • Enhancing the Efficacy of Docetaxel in Prostate Cancer  awarded by American Heart Association Principal Investigator Subaward 2022 - 2027
  • missing activity Principal Investigator Subaward 2022 - 2024

Background

Contact

full name

  • Paraskevi Giannakakou

primary email

  • pag2015@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Ownership refers to any financial stake an individual owns in any company (e.g., stock options, equity interest)Ownership:
    Arma Bio, Inc.
    Professional Services refers to a service requiring specialized knowledge and skill usually requiring a license, certification, or registration (e.g., expert witness, commissioned writing)Professional Services:
    Arma Bio, Inc.